These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1444722)

  • 21. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bulimia nervosa with co-morbid avoidant personality disorder: behavioural characteristics and serotonergic function.
    Bruce KR; Steiger H; Koerner NM; Israel M; Young SN
    Psychol Med; 2004 Jan; 34(1):113-24. PubMed ID: 14971632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls.
    Garcia-Borreguero D; Jacobsen FM; Murphy DL; Joseph-Vanderpool JR; Chiara A; Rosenthal NE
    Biol Psychiatry; 1995 May; 37(10):740-9. PubMed ID: 7640329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA; Murphy DL; Sunderland T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.
    Nappi RE; Sances G; Brundu B; De Taddei S; Sommacal A; Ghiotto N; Polatti F; Nappi G
    Hum Reprod; 2005 Dec; 20(12):3423-8. PubMed ID: 16123089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa.
    Bruce KR; Steiger H; Joober R; Ng Ying Kin NM; Israel M; Young SN
    Am J Med Genet B Neuropsychiatr Genet; 2005 Aug; 137B(1):40-4. PubMed ID: 15999344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.
    Kaye WH; Greeno CG; Moss H; Fernstrom J; Fernstrom M; Lilenfeld LR; Weltzin TE; Mann JJ
    Arch Gen Psychiatry; 1998 Oct; 55(10):927-35. PubMed ID: 9783564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder.
    Levitan RD; Kaplan AS; Brown GM; Vaccarino FJ; Kennedy SH; Levitt AJ; Joffe RT
    Arch Gen Psychiatry; 1998 Mar; 55(3):244-9. PubMed ID: 9510218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
    Bagdy G; Szemeredi K; Kanyicska B; Murphy DL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):72-8. PubMed ID: 2746512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism.
    Mortola JF; Rasmussen DD; Yen SS
    J Clin Endocrinol Metab; 1989 Mar; 68(3):517-22. PubMed ID: 2537336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased serotonin function in bulimia nervosa.
    Jimerson DC; Wolfe BE; Metzger ED; Finkelstein DM; Cooper TB; Levine JM
    Arch Gen Psychiatry; 1997 Jun; 54(6):529-34. PubMed ID: 9193193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated.
    Gordon ML; Lipton RB; Brown SL; Nakraseive C; Russell M; Pollack SZ; Korn ML; Merriam A; Solomon S; van Praag HM
    Cephalalgia; 1993 Dec; 13(6):400-5. PubMed ID: 8313453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects.
    Meltzer HY; Maes M
    Biol Psychiatry; 1994 Mar; 35(5):316-23. PubMed ID: 8011800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonergic dysfunction across the eating disorders: relationship to eating behaviour, purging behaviour, nutritional status and general psychopathology.
    Monteleone P; Brambilla F; Bortolotti F; Maj M
    Psychol Med; 2000 Sep; 30(5):1099-110. PubMed ID: 12027046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic sensitivity in borderline personality disorder: preliminary findings.
    Hollander E; Stein DJ; DeCaria CM; Cohen L; Saoud JB; Skodol AE; Kellman D; Rosnick L; Oldham JM
    Am J Psychiatry; 1994 Feb; 151(2):277-80. PubMed ID: 8296905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced plasma leptin concentrations in bulimia nervosa.
    Brewerton TD; Lesem MD; Kennedy A; Garvey WT
    Psychoneuroendocrinology; 2000 Oct; 25(7):649-58. PubMed ID: 10938446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation.
    Deakin JF; Pennell I; Upadhyaya AJ; Lofthouse R
    Psychopharmacology (Berl); 1990; 101(1):85-92. PubMed ID: 2343077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blunted oral body temperature response to MK-212 in cocaine addicts.
    Lee MA; Meltzer HY
    Drug Alcohol Depend; 1994 Jun; 35(3):217-22. PubMed ID: 7956751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA; Zohar J; Hill JL; Bernstein SE; Grover GN; Zohar-Kadouch RC; Murphy DL
    Biol Psychiatry; 1991 Mar; 29(5):418-26. PubMed ID: 2018816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.